184 related articles for article (PubMed ID: 25304761)
21. Marked hyperuricemia with acute renal failure: need to consider occult malignancy and spontaneous tumour lysis syndrome.
Agnani S; Gupta R; Atray NK; Vachharajani TJ
Int J Clin Pract; 2006 Mar; 60(3):364-6. PubMed ID: 16494656
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous tumor lysis syndrome in adrenal adenocarcinoma: a case report and review of the literature.
Shafie M; Teymouri A; Parsa S; Sadeghian A; Zarei Jalalabadi N
J Med Case Rep; 2022 Feb; 16(1):52. PubMed ID: 35139902
[TBL] [Abstract][Full Text] [Related]
23. The management of tumor lysis syndrome.
Rampello E; Fricia T; Malaguarnera M
Nat Clin Pract Oncol; 2006 Aug; 3(8):438-47. PubMed ID: 16894389
[TBL] [Abstract][Full Text] [Related]
24. Rapid Fire: Tumor Lysis Syndrome.
Dubbs SB
Emerg Med Clin North Am; 2018 Aug; 36(3):517-525. PubMed ID: 30037438
[TBL] [Abstract][Full Text] [Related]
25. Acute renal failure due to tumor lysis syndrome in a patient with non-Hodgkin's lymphoma.
Karagiannis A; Tsorlalis I; Kakafika A; Pateinakis P; Perifanis V; Harsoulis F
Ann Hematol; 2005 May; 84(5):343-6. PubMed ID: 15580501
[TBL] [Abstract][Full Text] [Related]
26. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
Baeksgaard L; Sørensen JB
Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
[TBL] [Abstract][Full Text] [Related]
27. Spontaneous tumor lysis syndrome in a child with T-cell acute lymphoblastic leukemia.
Kobayashi D; Wofford MM; McLean TW; Lin JJ
Pediatr Blood Cancer; 2010 May; 54(5):773-5. PubMed ID: 19998467
[TBL] [Abstract][Full Text] [Related]
28. A Rare Case of Spontaneous Tumor Lysis Syndrome in Idiopathic Primary Myelofibrosis.
Na YS; Park SG
Am J Case Rep; 2019 Feb; 20():146-150. PubMed ID: 30712053
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological treatment of acute and chronic hyperuricemia in kidney diseased patients.
Bellinghieri G; Santoro D; Savica D
Contrib Nephrol; 2005; 147():149-160. PubMed ID: 15604614
[TBL] [Abstract][Full Text] [Related]
30. Incidence and pathogenesis of tumor lysis syndrome.
Locatelli F; Rossi F
Contrib Nephrol; 2005; 147():61-68. PubMed ID: 15604606
[TBL] [Abstract][Full Text] [Related]
31. Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia: A Rare Case Report from Nephrology.
Armaly Z; Elias M; Yasin R; Hamzeh M; Jabbour AR; Artoul S; Saffouri A
Am J Case Rep; 2019 Nov; 20():1776-1780. PubMed ID: 31782952
[TBL] [Abstract][Full Text] [Related]
32. Role of serum sodium in assessing hospital mortality in cancer patients with spontaneous tumour lysis syndrome inducing acute uric acid nephropathy.
Hsu HH; Chen YC; Tian YC; Chan YL; Kuo MC; Tang CC; Fang JT; Lee SY; Yang CW
Int J Clin Pract; 2009 May; 63(5):751-6. PubMed ID: 19402210
[TBL] [Abstract][Full Text] [Related]
33. Rasburicase therapy in acute hyperuricemia and renal dysfunction.
Ronco C; Inguaggiato P; Bordoni V; De Cal M; Bonello M; Andrikos E; Assuman Y; Rattanarat R; Bellomo R
Contrib Nephrol; 2005; 147():115-123. PubMed ID: 15604611
[TBL] [Abstract][Full Text] [Related]
34. Tumour lysis syndrome.
Calvo Villas JM
Med Clin (Barc); 2019 May; 152(10):397-404. PubMed ID: 30612747
[TBL] [Abstract][Full Text] [Related]
35. Tumor Lysis Syndrome: Implications for Oncology Nursing Practice.
Webster JS; Kaplow R
Semin Oncol Nurs; 2021 Apr; 37(2):151136. PubMed ID: 33744034
[TBL] [Abstract][Full Text] [Related]
36. Spontaneous Tumor Lysis Syndrome in Diffuse Large B-cell Lymphoma: Early Diagnosis and Management.
Gangireddy M; Shrimanker I; Nookala VK; Peroutka KA
Cureus; 2019 May; 11(5):e4679. PubMed ID: 31328070
[TBL] [Abstract][Full Text] [Related]
37. Utilization patterns and clinical outcomes of rasburicase administration according to tumor risk stratification.
Khalighi PR; Martens KL; White AA; Li S; Silgard E; Frieze D; Garcia DA; Li A
J Oncol Pharm Pract; 2020 Apr; 26(3):529-535. PubMed ID: 31167612
[TBL] [Abstract][Full Text] [Related]
38. [Rasburicase (Fasturtec)].
Vogt B; Gugger M; Frey FJ
Ther Umsch; 2004 Sep; 61(9):579-82. PubMed ID: 15493120
[TBL] [Abstract][Full Text] [Related]
39. Rational use of rasburicase for the treatment and management of tumor lysis syndrome.
Shaikh SA; Marini BL; Hough SM; Perissinotti AJ
J Oncol Pharm Pract; 2018 Apr; 24(3):176-184. PubMed ID: 28077046
[TBL] [Abstract][Full Text] [Related]
40. Single 4.5 mg fixed-dose of rasburicase for hyperuricemia associated with tumor lysis syndrome.
Patel KS; Lau JE; Zembillas AS; Gallagher EM
J Oncol Pharm Pract; 2017 Jul; 23(5):333-337. PubMed ID: 27084514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
